InvestorsHub Logo

Lemoncat

09/19/20 7:28 PM

#324448 RE: thefamilyman #324440

Nah. Will be something like the following:

$30M upfront + $50M upon approval + 9% royalty
Gilead assumes all trial costs, regulatory, distribution, etc.
Brilacidin for COVID remains a combo-only treatment.

Would be a tremendous deal for us. Stock price would shoot over $1 on the announcement.

Go IPIX!